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In continuing our 10th Anniversary celebrations, we asked a number of editorial board members for
their reflections on the field of metabolism.A Long and Winding RoadAna Maria Cuervo Jeffrey GordonOver the past decade, we’ve come
to understand that obesity and diabetes
aremuchmoreheterogeneousdisorders
than previously envisaged—and ones
where the pathophysiology involves
many pathways and organ systems.
Nevertheless, we’ve made remarkable
progress. Highlights such as newhuman
genetic variants come to mind—think
TCF7L2 and melanocortin-4 receptor.
Novel pathways like FGF21 and adipo-
nectin were also carefully mapped, and
we now appreciate the roles that inflam-
mation, circadian rhythms, and the
microbiome have in metabolic disease.
Our common goal is to advance
the science toward new therapies, yet
here’s where we face the biggest ob-
stacles. The good news is that several
newer therapeutic classes have actu-
ally come to the fore; among these are
inhibitors of dipeptidyl peptidase-4
and sodium-glucose transporter-2 and
agonists of glucagon-like peptide-1
and 5-HT2c receptors. The challenge
is that developing new medicines is
arduous and complex. Researchers
must evaluate whether a new mecha-
nism will ‘‘translate’’ from animal to hu-
man efficacy, assess what dosage will
be required, and address potential
safety risks. They must also explore
practical issues like chemical stability,
manufacturing challenges, and costs.
Since the launch of Cell Metabolism
10 years ago, there’s been a quantum
leap in the number of available drug
targets. As scientists, we must remain
focused on identifying those mecha-
nisms that have the greatest potential
to help make life better for people
around the world.
Lilly Research LaboratoriesIt’s All about Recycling!At the autophagy renascence peak, it
is fascinating to see words such as
‘‘energy’’ and ‘‘metabolism’’ return to
this field. Autophagic degradation and
recycling of cellular contents was
described as a mechanism to cope
with low nutrient availability. However,
later-discovered roles in cellular quality
control linked autophagic dysfunc-
tion with degenerative diseases and
partially eclipsed other autophagy
functions. In recent years, we have
been reminded of the ‘‘old role’’ of
autophagy in metabolism by discov-
eries such as the autophagic degrada-
tion of lipid and glycogen stores, its
intricate connections with nutrient
sensing, or its prime role in sustaining
tumors’ high metabolic demands.
The autophagic defense against lipo-
and glucotoxicity has connected auto-
phagy malfunction with metabolic
disorders such as diabetes, obesity,
and atherosclerosis.
Full understanding of the autophagy-
metabolism interplay requires now
conceptual and experimental shifts
driven by the non-linear and bidirec-
tional nature of their regulation and
the importance of flux in both pro-
cesses. Furthermore, the contribution
of different organs to metabolism is
unique and often opposite, making
necessary a cell-autonomous yet or-
gan-integrate regulation of autophagy.
Transition from ‘‘snapshot’’ analysis of
autophagy toward dynamic and inte-
grative system biology approaches
with multiple inputs, bidirectionality,
and flux could make the therapeutic
potential of autophagy manipulation
in metabolic disorders a reality.
Albert Einstein College of MedicineCell Metabolism‘‘Our’’ Microbes!Interdisciplinary studies of the human
microbiome are allowing us to ‘‘see’’
ourselves as a splendid assemblage
of interacting human and microbial
parts. Integrating microbes into our
concept of self is changing our views
of the origins of our ‘‘human’’ metabo-
types. This broader perspective is
appropriate (after all, microbes rule
the world), but also timely given
how changing cultural traditions and
globalization are altering our microbial
ecology. There is much to consider in
this defining century for humanity,
but add this to the list: how can we be
better stewards of our humanmicrobial
resources, now and for subsequent
generations? Identifying which mem-
bers of our microbial communities
shape various features of our meta-
bolism is a daunting challenge, but
the effort is inspiring (microbes can
teach us so much more about
biochemistry). The good news is that
preclinical models are available that
can incorporate our human microbial
communities so that their expressed
functions can be studied and the
results used to design and interpret
human studies. Our microbiomes
should provide a wealth of new bio-
markers of health status and new ther-
apeutic targets and agents. Looking
ahead, Cell Metabolism should be
a welcoming platform for describing
the results of these efforts to under-
stand our microbial selves in the
context of the different ways we live
our lives today and tomorrow.
Washington University in St. Louis21, April 7, 2015 ª2015 Elsevier Inc. 505
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VoicesReinventing the Unbiased
Biological HypothesisPhilippe Froguel
Faculty of Medicine, School of Public Health,
David J. Mangelsdorf
University of Texas Southwestern Medical CenterClaude Bernard, the father of Meta-
bolism, had warned us: ‘‘Never be in
love with your hypothesis; don’t try
to reinforce it but do your best to
destroy it using appropriate experi-
ments.’’ In contrast, many biologists
do their very best to validate their
idea. Is that why 80% of our papers
are wrong? As a reviewer, you often
ask an author for a couple of new ex-
periments to verify surprising data,
and what happens? Actually, 100% of
the extra work succeeds in ways sup-
porting the original hypothesis, which
is far against the odds. Some have
blamed the rather primitive statistics
in biology and insufficient number of
animals. Can the ‘‘hypothesis-driven’’
research be biased? Geneticists have
painfully learned the lesson of true
unbiased genomics, where the only
researcher privilege is to establish and
control the technical aspects of the
whole-genome study. The outcome is
fully based on probabilities, which
protect the observer against himself.
Although (single-cell) omics is the
new battlefield for biologists, they
should use it to generate most plau-
sible biological hypotheses (e.g.,
candidate genes and pathways) rather
than being only the icing on the cake
of extensive cellular studies based on
a weak hypothesis. Systems biology
should be the biologist’s muse and
not their slave.
Imperial College London506 Cell Metabolism 21, April 7, 2015 ª2015‘‘Safe Science’’One of the best pieces of advice for
junior faculty that I have ever heard
came from Nobel laureate Alfred Gil-
man: ‘‘Don’t practice safe science!’’
His message was clear: let the results
of your experiments guide the direction
of your research, and then be bold
enough to follow that direction—wher-
ever it takes you. Almost certainly it
will lead down an interesting path.
Consider, for example, the field of
nuclear receptors, which was founded
based on the sex steroid receptors
and their regulation of reproduction
and development. It turns out that
steroid receptors were just the tip of a
much bigger iceberg that includes
dozens of novel orphan receptors,
the characterization of which led the
field down an unexpected path into
the realm of metabolism. Although
this was uncharted territory, it did not
slow down an invasion of adventurous
scientists into the metabolism field.
Notably, in the past 10 years over
120 papers on nuclear receptors
have been published in the pages of
Cell Metabolism—an average of one
per issue. The intrepid investigation
of those receptors changed our view
of metabolism as much as metabolism
changed our view of nuclear receptors.
Just another example of how not
practicing safe science can spread
the disease of discovery.Elsevier Inc.
